Mihir Parikh

ORCID: 0000-0003-4284-2030
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tracheal and airway disorders
  • Airway Management and Intubation Techniques
  • Pleural and Pulmonary Diseases
  • Lung Cancer Diagnosis and Treatment
  • Dysphagia Assessment and Management
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Trauma Management and Diagnosis
  • Respiratory Support and Mechanisms
  • Pneumothorax, Barotrauma, Emphysema
  • Medical Imaging and Pathology Studies
  • Esophageal and GI Pathology
  • Ultrasound in Clinical Applications
  • Epilepsy research and treatment
  • Voice and Speech Disorders
  • Lung Cancer Treatments and Mutations
  • Cardiac Arrest and Resuscitation
  • Vascular Anomalies and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies
  • Central Venous Catheters and Hemodialysis
  • Congenital Diaphragmatic Hernia Studies
  • COVID-19 and healthcare impacts
  • Family and Patient Care in Intensive Care Units
  • Respiratory and Cough-Related Research
  • Advanced Radiotherapy Techniques

Hadassah Medical Center
2019-2025

Harvard University
2012-2025

Beth Israel Deaconess Medical Center
2017-2025

Parul University
2025

The University of Texas Southwestern Medical Center
2019-2024

NVision Eye Centers (United States)
2023

Icahn School of Medicine at Mount Sinai
2008-2022

Children's Hospital of Philadelphia
2020

Pulmonary and Critical Care Associates
2020

SleepMed
2020

Gerard J. Criner Richard Sue Shawn E. Wright Mark T. Dransfield Hiram Rivas-Perez and 95 more Tanya Wiese Frank C. Sciurba Pallav L. Shah Momen M. Wahidi Hugo Goulart de Oliveira Brian Morrissey Paulo Francisco Guerreiro Cardoso Steven R. Hays Adnan Majid Nicholas J. Pastis Lisa Kopas Mark Vollenweider P. Michael McFadden Michael Machuzak David W. Hsia Arthur Sung Nabil Jarad Malgorzata Kornaszewska Stephen R. Hazelrigg Ganesh Krishna Brian Armstrong Narinder S. Shargill Dirk‐Jan Slebos Gerard J. Criner Francis Cordova Parag Desai Nathaniel Marchetti Victor Kim Kartik Shenoy John M. Travaline Jiji Thomas Lii-Yoong H. Criner Richard Sue Shawn E. Wright Aaron Thornburg Terry Thomas Mark T. Dransfield Surya P. Bhatt J. Michael Wells Necole Seabron-Harris Hiram Rivas-Perez Umair Gauhar Tanya Wiese Crissie Despirito Frank C. Sciurba Jessica Bon Field Divay Chandra Joseph K. Leader Roy Semaan Christina M. Ledezma Pallav L. Shah Samuel V. Kemp Justin Garner Arafa Aboelhassan Karthi Srikanthan Eric Daniel Tenda A.M López Abraham Cai Sim Momen M. Wahidi Kamran Mahmood Scott Shofer Kathleen Coles Hugo Goulart de Oliveira Guilherme A. P. de Oliveira Betina Machado Igor Gorski Benedetto Fábio Munhoz Svartman Amarilio de Macedo Neto Leonardo Schreiner Taiane Alves Vieira Brian Morrissey Ken Y. Yoneda Tristan Tham Daniel Tompkins Paulo Francisco Guerreiro Cardoso Rodrigo Abensur Athanazio Felipe Nominando Samia Zahi Rached Luciana Cassimiro Steven R. Hays Eric J. Seeley Pavan Shrestha Gabriela R. Dincheva Adnan Majid Daniel Alape Mihir Parikh Alichia Paton A. Agnew Nicholas J. Pastis Charlie Strange Tatsiana Beiko Danielle Woodford Mary Blanton Lisa Kopas Timothy M. Connolly

Rationale: This is the first multicenter randomized controlled trial to evaluate effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little no collateral ventilation out 12 months.Objectives: To EBV heterogeneous emphysema treated lobe.Methods: Subjects were enrolled a 2:1 randomization (EBV/standard care [SoC]) at 24 sites. Primary outcome months was ΔEBV–SoC subjects post-bronchodilator FEV1 improvement from baseline greater than or equal 15%. Secondary endpoints...

10.1164/rccm.201803-0590oc article EN American Journal of Respiratory and Critical Care Medicine 2018-05-22
Gerald Matchett Irina Gasanova Christina A. Riccio Dawood Nasir Mary Sunna and 95 more Brian J. Bravenec Omaira Azizad Brian Farrell Abu Minhajuddin Jesse W. Stewart Lawrence W. Liang Tiffany S. Moon Pamela E. Fox Callie Ebeling Miakka N. Smith Devin M. Trousdale Babatunde Ogunnaike Anand M. Abraham Robert S. Ackerman Oluwafunmilayo B. Adebayo-Adonis Venkatesh Aiyagari Aditee P. Ambardekar Kelechi B. Anyaehie David M. Bashover Matthew Burke Bourneuf James R. Brann Grace Wilkowski Bryant Matthew P. Bunker Leigh Anne Catoe Catherine Chen Jeffrey S. Chen Joy Lo Chen Gloria Cheng Ivan Nicholas Chew Jeanette Chin Samuel M. Cohen Mary Abigail Cowlishaw Janice Davis Jennifer L. Davis TomMario Alando Davis David G. DePinto Paul E. Dilfer Renee D. Doherty Philip James DuChamp Katherine L. Duncan Colin C. Ehlenbach Ahmad Elsharydah Sonia D. Estes Akil Farishta William Eric Foster David Francis Shannon Garitty Nicholas W. Gill Louise A. Gliga Joseph Arthur Graham Nancy B. Greilich Jessica E. Grundt Allan J. Hamilton Hooman Heravi Douglas C. Huynh Ray K. Hwong Rachel E. Jacobs Syed Jaffery Aveline P. Jerome Suja John Enas Kandil Asif Khan Sarah Khorsand Jennifer Meeyun Kim Elena Koepke Grayson Jeffrey Koval Brian P. Kurtz Xuan T. Langridge Gene W. Lee Simon J. Craddock Lee Matthew Leveno Dawn Lewellen Frederick C. Li Nathaniel Loo Xi Luo Rachelle A. Makinde Anna Martin Evan Z. Mayes Diane E. McCune John McGrimley Jennifer J. McGuire Kyle Meinhardt Akeel Merchant Zahid Merchant David Mercier Brandon Mitchell Andrea J. Murray Shamsideen O. Musa Geoffrey Edward Nelson Seth Nelson L. H. Nguyen Linsey Nohrn Osamudiamen O. Obanor Chinwe C. Ononogbu Mihir Parikh

10.1007/s00134-021-06577-x article EN Intensive Care Medicine 2021-12-14

PurposeTo compare the ocular hypotensive efficacy and safety of a fixed-dose combination (FDC) Rho kinase inhibitor netarsudil latanoprost vs monotherapy with or latanoprost.DesignThree-month primary endpoint analysis randomized, double-masked, phase 3 clinical trial.MethodsAdults open-angle glaucoma hypertension (unmedicated intraocular pressure [IOP] >20 <36 mm Hg at 8:00 AM) were randomized to receive once-daily netarsudil/latanoprost FDC, 0.02%, 0.005% for up 12 months. The was mean IOP...

10.1016/j.ajo.2019.06.016 article EN cc-by-nc-nd American Journal of Ophthalmology 2019-06-21

Traditional bronchoscopy provides limited approach to peripheral nodules. Shape-sensing robotic-assisted (SSRAB, Ion™ Endoluminal System) is a new tool for minimally invasive nodule biopsy. We sought answer the research question: Does SSRAB facilitate sampling of pulmonary nodules during bronchoscopists' initial experience?The lead-in stage multicenter, single-arm, prospective evaluation Ion System (PRECIsE) described. Enrolled subjects ≥ 18 years old had recent computed tomography evidence...

10.1186/s12890-021-01693-2 article EN cc-by BMC Pulmonary Medicine 2021-10-16

Rationale: Pleural infection is frequently encountered in clinical practice and associated with high morbidity mortality. Limited evidence exists regarding the optimal treatment. Although both early medical thoracoscopy (MT) tube thoracostomy intrapleural instillation of tissue plasminogen activator human recombinant deoxyribonuclease are acceptable treatments for patients complicated pleural infection, there a lack comparative data these modes management.Objectives: The aim this study was...

10.1513/annalsats.202001-076oc article EN Annals of the American Thoracic Society 2020-05-18

Effective communication between intensive care unit (ICU) providers and families is crucial given the complexity of decisions made regarding goals therapy. Using video images to supplement medical discussions an innovative process standardize improve communication. In this six-month, quasi-experimental, pre-post intervention study we investigated impact a cardiopulmonary resuscitation (CPR) decision support tool upon knowledge about CPR among surrogate makers for critically ill adults.We...

10.1089/jpm.2012.0215 article EN Journal of Palliative Medicine 2012-10-25

We used a living bilayered cultured skin replacement to close full-thickness wound defects on the dorsum of athymic mice. The is composed human fibroblasts that condense bovine collagen lattice; lattice then seeded with keratinocytes. serves as dermal template, and overlying keratinocytes form epidermal component this composite replacement. Twenty-four animals were grafted, groups six killed biopsied at 6, 15, 30, 60 days after graft mice in control group receiving grafts fresh,...

10.1097/00004630-199407000-00010 article EN Journal of Burn Care & Rehabilitation 1994-07-01

Treatment of pleural infection with instillation sequential intrapleural tissue plasminogen activator (tPA) and human recombinant deoxyribonuclease (DNase) twice daily for a total 6 doses has been shown to decrease surgical referral improve radiographic imaging. This labor-intensive regimen was empirically chosen. Thus, it remains unclear whether the 2 drugs can be administered immediately one after other (concurrent administration) instead instilling them separately 1-hour 2-hour interval...

10.1097/lbr.0000000000000461 article EN Journal of Bronchology & Interventional Pulmonology 2018-01-17

Aims Fam-trastuzumab deruxtecan-nxki (T-DXd) was recently approved for advanced stage or metastatic solid tumours with human epidermal growth factor receptor 2 (HER2) immunohistochemical (IHC) 3+ staining. Data on HER2 IHC testing and knowledge of genomic correlates in lung cancer are scarce. This study analyses characteristics HER2-expressing addresses issues preanalytical variables specimens. Methods staining performed selected archival cytology surgical pathology specimens patients...

10.1136/jcp-2025-210095 article EN Journal of Clinical Pathology 2025-03-12

10.1164/ajrccm.2025.211.abstracts.a2036 article EN American Journal of Respiratory and Critical Care Medicine 2025-05-01
Coming Soon ...